HomeChimiothèquesCambridge Cancer Compound Library

Cambridge Cancer Compound Library

Réf. Cat.L2300

Une collection unique de 242 composés anticancéreux pour le criblage à haut débit (HTS) et le criblage à contenu élevé (HCS).

96 well plates

Personnalisez votre bibliothèque:

Cité par 334 Publications

Cambridge Cancer Compound Library Contenu

Description & Avantages

• A highly value-added library derived through a collaboration with researchers at the MIT Koch Institute
• A unique collection of cancer-targeted compounds for high throughput screening (HTS) and high content screening (HCS)
• Embraces the whole spectrum of cancer targets, from kinases to notch signaling, to metabolic targets
• Structurally diverse, medicinally active and cell permeable
• Rich documentation with structure
• NMR and HPLC to ensure the high purity

Détails du produit

Formulation 242 compounds pre-dissolved in 10mM DMSO
Conteneur Plaque à 96 puits profonds scellée avec du papier daluminium
Stabilité 12 months -20°C in DMSO
24 months -80°C in DMSO
Expédition Glace bleue ou glace sèche

Études de cas utilisant les bibliothèques de composés Selleck

Cambridge Cancer Compound Library Composition

Partenaires de linstallation HTS

  • Collaborating with Seleck: Yale University | Yale Center for Molecular Discovery
  • Collaborating with Seleck: Carbone Cancer Center | University of Wisconsin-Madison
  • Collaborating with Seleck: University of Colorado Denver | CU Denver
  • Collaborating with Seleck: Leibniz-Forschungsinstitut für Molekulare Pharmakologie: Leibniz-FMP
  • Collaborating with Seleck: UCSF_University of California San Francisco
  • Collaborating with Seleck: KU | High Throughput Screening Laboratory
  • Collaborating with Seleck: CIBIO
  • Collaborating with Seleck: Perelman school of medicine | University of Pennsylvania